Guardant Health, Inc.

Guardant Health, Inc. reported revenue of $982.0 million for fiscal year 2025, representing growth from the prior year. The company incurred a net loss of $416.3 million, with an operating loss of $437.2 million. Key cost drivers included sales and marketing expenses of $494.7 million and research and development expenses of $364.2 million. The balance sheet shows total assets of...